---
title: Efficacy of a Novel Water-Free Topical Cyclosporine 0.1 % Solution for Optimizing
  the Ocular Surface in Patients with Dry Eye and Cataract
date: '2024-02-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38334413/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240209170550&v=2.18.0
source: heidelberg[Affiliation]
description: 'This is a pooled analysis from two phase III clinical trials investigating
  a water-free topical cyclosporine 0.1% for the treatment of moderate to severe dry
  eye. The analyses included 1162 patients: 35% with cataract, 20% with pseudophakia
  and 45% without cataract. Demographics or baseline characteristics were comparable
  across groups except for age and vision. The cyclosporine treated patients achieved
  large mean improvements from baseline by day 15: -3.7 in patients without cataract,
  -3.2 ...'
disable_comments: true
---
This is a pooled analysis from two phase III clinical trials investigating a water-free topical cyclosporine 0.1% for the treatment of moderate to severe dry eye. The analyses included 1162 patients: 35% with cataract, 20% with pseudophakia and 45% without cataract. Demographics or baseline characteristics were comparable across groups except for age and vision. The cyclosporine treated patients achieved large mean improvements from baseline by day 15: -3.7 in patients without cataract, -3.2 ...